Precision management of urinary tract symptoms in older women
Official title: Precision Management of Urinary Tract Symptoms in Older Women: A Randomized Trial to Reduce Overtreatment
Run by University of Pittsburgh · NCT07686055 · Data updated 2026-11-12
This trial tests three ways to treat urinary tract symptoms in women 65 and older to see which approach works best and minimizes unnecessary antibiotic use.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | July 23, 2026 |
| Main results expected | February 1, 2027 |
| Study ends | February 14, 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07686055 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 65 or older with a history of recurrent UTIs who experience current UTI symptoms as defined by dysuria, urgency/frequency, or suprapubic pain.
✕Probably not a fit
Patients unlikely to benefit may include those with non-UTI causes of symptoms or with complex comorbidities that affect outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3 randomized trial compares empiric antibiotics, urinalysis-guided therapy, and culture-directed care for urinary tract symptoms in women aged 65 and older with a history of recurrent UTIs. Participants are enrolled from UPMC and a research registry and followed for 28 days after randomization. The study combines patient-reported outcomes with laboratory data to determine which strategy benefits patients the most while supporting antibiotic stewardship. The goal is to identify precision care pathways that improve symptoms and quality of life in a high-risk population. Results could guide more targeted, effective management of recurrent UTIs in older women.
Why it matters
Potential benefit: If successful, the trial could identify which patients can avoid unnecessary antibiotics without compromising symptom control.
How similar studies have gone: Prior studies have explored targeted antibiotic strategies, but this trial advances precision care by directly comparing three management approaches in a high-risk, older population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female biologic Sex * Age ≥65 years old * History of recurrent UTI per patient report of greater than 2 UTIs in the last 6 months or 3 UTIs in the last year * Patient reported UTI defined as: * Dysuria, increased urinary urgency/frequency and/or suprapubic pain Exclusion Criteria: * Male biologic sex * Age \<65 years old * History of augmentation cystoplasty or cystectomy * Currently performing clean intermittent self-catheterization * Current indwelling foley catheter * Urinary tract instrumentation (i.e., cystourethroscopy, foley catheter placement) in the last 30 days * Undergoing treatment for malignancy * History of either confirmed or patient reported pyelonephritis and/or urosepsis * Cirrhosis and/or end stage liver disease * Chronic kidney disease with most recent estimated glomerular filtration rate \<50 ml/min * Dementia and/or currently reside in skilled nursing facility * Current high-dose chronic steroids (\>20mg/day of prednisone) * Previous solid organ transplant * Provider concern for pyelonephritis and/or sepsis (i.e., fevers) * Unwilling or unable to comply with study procedures (including ability to complete electronic questionnaires)
Where it's running
-
UPMC-Magee Womens Hospital
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Megan Bradley, MD, MSc — University of Pittsburgh
- Study coordinator: Megan S Bradley, MD MSc
- Email: bradleym4@upmc.edu
- Phone: 412-641-7850
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric oxygen for chronic radiation cystitis
This project will try hyperbaric oxygen therapy in adults with moderate to severe radiation cystitis to see if symptoms improve and urine inflammatory markers change.
-
Intravesical Lactobacillus crispatus for urinary health in people with neurogenic bladder
This study will test whether putting Lactobacillus crispatus into the bladder can help reduce urinary symptoms and urinary tract infections in adults with neurogenic lower urinary tract dysfunction who use intermittent catheters.
-
New care guideline for infants 60 days and younger with fever in Sweden
This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.
-
Investigating the link between urinary tract infections and preeclampsia in pregnant women
This study is trying to see if having a urinary tract infection during pregnancy is linked to developing preeclampsia in pregnant women.
-
Methenamine Hippurate After BOTOX-A Injections for Overactive Bladder
This study tests whether methenamine hippurate can prevent urinary infections after BOTOX-A injections in women with overactive bladder, compared with standard antibiotic prophylaxis.
-
Preoperative urine infections and colonization in older adults having bone and orthopedic surgery
This will see if having a urinary infection or colonization before bone or orthopedic surgery raises the risk of postoperative complications in people aged 65 and older.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.